REFERENCES
- Martindale. The Extra Pharmacopoeia. 30th ed., Pharmaceutical Press, London 1993
- Brogden R. N, Heel R. C., Speight T. M., Avery G. S. Piroxicam, a reappraisal of its pharmacology and therapeutic efficacy. Drugs 1984; 28: 192–323
- Herzfeldt C. D, Kummel R. Dissociation constants, solubitlities and dissolution rates anti-inflammatories. Drug Dev. Ind. Pharm. 1983; 9(5)767–793
- U.S.Pharmacopeial Convention. United States Pharmacopoeia 23/National Formulary 18. Author, Rockville, , MD 1995
- Barone J. A., Lordi N. G., Byerly W. G., Colaizzi J. L. Comparitive dissolution performance of internationally available piroxicam products. Drug Intell. Clin. Pharm. 1998; 22: 35–40, January
- Mihalić M., Hofman H., Kuftinec J., Krile B., Caplar V., Kajfez F., Blazevic N. Piroxicam. Analytical Profiles of Drug Substances, K. Florey. Academic, New York 1986; 15
- Vrecer F., Srcic S., Smid-Korbar J. Investigation of piroxicam polymorphism. Int. J. Pharm. 1991; 68: 35–41
- Fincher J. H. Particle size of drugs and its relationship to absorption and activity. J. Pharm. Sci. 1968; 57(11)1835, November 1968
- De Villiers M. M. Influence of cohesive properties of micronized drug powders on particle size analysis. J. Pharm. Biomed. Anal. 1995; 13(3)191–198
- Chuiou W. L., Riegelman S. Pharmacological application of solid dispersions. J. Pharm. Sci. 1971; 60(9)1281–1302
- Najib N. M., Suleiman M. S. The effect of hydrophilic polymers and surface active agents on the solubility of indomethacin. Int. J. Pharm. 1985; 24: 165–171
- Ganley J. A., McEwen J., Calvent R. T., Barker C. J. The effect of in vivo dispersion and gastric emptying on glibenclamide absorption from a novel, rapidly dissolving capsule formulaition. J. Pharm. Pharmacol. 1984; 36: 734–739
- Suleiman M. S., Najib N. M. Isolation and physicochemical charaterization of solid forms of glibenclamide. Int. J. Pharm. 1989; 50: 103–109
- Fukuoka E., Makita M., Yamamura S. Some physico-chemical properties of glassy indomethacin. Chem. Pharm. Bull. 1986; 34(10)4314–4321
- Chowdhary K. P. R., Mathusudhan P. Effect of primogel and surfactants on the dissolution of piroxicam from capsule formulations. Eastern Pharm. 1990; 33(387)143–144, March 1990
- Pepin X., Blanchon S., Couraraze G. Powder dynamic contact angle measurements: Young contact angles and effectively wet perimeters. Powder Technol. 1998; 99: 264–271
- Moore J. W., Flanner H. H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996; 20(6)64–74, June 1996
- Bordner J., Richards J. A., Weeks P., Whipple E. B. Piroxicam monohydrate: a zwitterionic form. Acta Crystalloger. Sect. C: Cryst. Struct. Commun. 1984; 40(6)989
- Patel R. B., Shah G. F., Jain S. M., Gandhi T. P., Patel M. R. Single dose bioavailability study of different piroxicam formulation. Indian Drugs 1987; 25(8)325–328